Thursday, July 27, 2017

Oncogene - Table of Contents alert Volume 36 Issue 30

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
New to ChIP?

Beginners are welcome.
  • ChIP and ChIP-seq – easy kits, even for beginners.
  • Validated ChIP antibodies – they work the first time!
  • Bioruptor chromatin shearing systems – cited over 4,000 times.
  • ChIP/ChIP-seq automation
Learn more

TABLE OF CONTENTS

Volume 36, Issue 30 (July 2017)

In this issue
Original Articles
Corrigenda

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Celebrating 30 years of Oncogene — 1987 to 2017

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video showing a brief impact overview >>>
 

Original Articles

Top

Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling

X Tang, C-K Ding, J Wu, J Sjol, S Wardell, I Spasojevic, D George, D P McDonnell, D S Hsu, J T Chang and J-T Chi

Oncogene 2017 36: 4235-4242; advance online publication, November 21, 2016; 10.1038/onc.2016.394

Abstract | Full Text

GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness OPEN

M-C Lin, J-J Lin, C-L Hsu, H-F Juan, P-J Lou and M-C Huang

Oncogene 2017 36: 4243-4252; advance online publication, March 6, 2017; 10.1038/onc.2017.8

Abstract | Full Text

OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness

E Comisso, M Scarola, M Rosso, S Piazza, S Marzinotto, Y Ciani, M Orsaria, L Mariuzzi, C Schneider, S Schoeftner and R Benetti

Oncogene 2017 36: 4253-4266; advance online publication, March 20, 2017; 10.1038/onc.2017.20

Abstract | Full Text

Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells OPEN

H Takahashi, J Inoue, K Sakaguchi, M Takagi, S Mizutani and J Inazawa

Oncogene 2017 36: 4267-4276; advance online publication, March 27, 2017; 10.1038/onc.2017.59

Abstract | Full Text

Deletion of endothelial cell-specific liver kinase B1 increases angiogenesis and tumor growth via vascular endothelial growth factor

W Zhang, Y Ding, C Zhang, Q Lu, Z Liu, K Coughlan, I Okon and M-H Zou

Oncogene 2017 36: 4277-4287; advance online publication, March 27, 2017; 10.1038/onc.2017.61

Abstract | Full Text

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer OPEN

N L E Harris, C Vennin, J R W Conway, K L Vine, M Pinese, M J Cowley, R F Shearer, M C Lucas, D Herrmann, A H Allam, M Pajic, J P Morton, Australian Pancreatic Cancer Genome Initiative, A V Biankin, M Ranson, P Timpson and D N Saunders

Oncogene 2017 36: 4288-4298; advance online publication, March 27, 2017; 10.1038/onc.2017.63

Abstract | Full Text

Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist

D Ruan, J He, C-F Li, H-J Lee, J Liu, H-K Lin and C-H Chan

Oncogene 2017 36: 4299-4310; advance online publication, March 27, 2017; 10.1038/onc.2017.64

Abstract | Full Text

MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes OPEN

E Taylor, N Alqadri, L Dodgson, D Mason, E Lyulcheva, G Messina and D Bennett

Oncogene 2017 36: 4311-4322; advance online publication, March 27, 2017; 10.1038/onc.2017.68

Abstract | Full Text

The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells OPEN

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao, X Wen, A Lu, M Wang, M Zheng, J Ji and J Sun

Oncogene 2017 36: 4323-4335; advance online publication, March 27, 2017; 10.1038/onc.2017.74

Abstract | Full Text

TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function OPEN

D R Principe, A M Diaz, C Torres, R J Mangan, B DeCant, R McKinney, M-S Tsao, A Lowy, H G Munshi, B Jung and P J Grippo

Oncogene 2017 36: 4336-4348; advance online publication, April 3, 2017; 10.1038/onc.2016.500

Abstract | Full Text

JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21 OPEN

B Colleoni, S Paternot, J M Pita, X Bisteau, K Coulonval, R J Davis, E Raspé and P P Roger

Oncogene 2017 36: 4349-4361; advance online publication, April 3, 2017; 10.1038/onc.2017.7

Abstract | Full Text

DNA-binding mechanism of the Hippo pathway transcription factor TEAD4

Z Shi, F He, M Chen, L Hua, W Wang, S Jiao and Z Zhou

Oncogene 2017 36: 4362-4369; advance online publication, April 3, 2017; 10.1038/onc.2017.24

Abstract | Full Text

Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer

A M Ohm, A-C Tan, L E Heasley and M E Reyland

Oncogene 2017 36: 4370-4378; advance online publication, April 3, 2017; 10.1038/onc.2017.27

Abstract | Full Text

Corrigenda

Top

Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling

X Tang, C-K Ding, J Wu, J Sjol, S Wardell, I Spasojevic, D George, D P McDonnell, D S Hsu, J T Chang and J-T Chi

Oncogene 2017 36: 4379; advance online publication, June 12, 2017; 10.1038/onc.2017.192

Full Text

GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness OPEN

M-C Lin, J-J Lin, C-L Hsu, H-F Juan, P-J Lou and M-C Huang

Oncogene 2017 36: 4380; advance online publication, June 12, 2017; 10.1038/onc.2017.196

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: